Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › MI › GRAND RAPIDS › CANCER & HEMATOLOGY CENTERS OF WESTERN MI, P.C.

CANCER & HEMATOLOGY CENTERS OF WESTERN MI, P.C.

NPI: 1528018389 · GRAND RAPIDS, MI 49503 · Specialist · NPI assigned 05/11/2006

$59.56M
Total Medicaid Paid
449,502
Total Claims
302,167
Beneficiaries
147
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialGENSCHAW, STUART (EXECUTIVE DIRECTOR)
NPI Enumeration Date05/11/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 63,338 $9.30M
2019 55,875 $8.34M
2020 60,747 $8.67M
2021 68,718 $9.40M
2022 64,796 $8.68M
2023 68,656 $7.07M
2024 67,372 $8.11M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
J9271 Injection, pembrolizumab, 1 mg 2,325 1,768 $16.87M
J9299 Injection, nivolumab, 1 mg 2,633 1,622 $12.36M
J2505 Injection, pegfilgrastim, 6 mg 1,515 1,139 $4.50M
J9173 Injection, durvalumab, 10 mg 468 304 $2.09M
Q5122 Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg 886 651 $1.87M
Q5117 Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg 839 527 $1.87M
J9355 Injection, trastuzumab, excludes biosimilar, 10 mg 606 305 $1.67M
J9306 Injection, pertuzumab, 1 mg 292 213 $1.44M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 27,073 14,357 $1.43M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 25,627 23,101 $1.34M
J9035 Injection, bevacizumab, 10 mg 510 268 $1.34M
Q5107 Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg 565 306 $872K
J1930 Injection, lanreotide, 1 mg 225 212 $784K
G9678 Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation agreement 5,237 5,178 $776K
J1439 Injection, ferric carboxymaltose, 1 mg 1,336 839 $760K
99233 Prolong inpt eval add15 m 13,648 2,547 $759K
99215 Prolong outpt/office vis 10,001 9,012 $731K
99223 Prolong inpt eval add15 m 4,512 4,184 $434K
J2469 Injection, palonosetron hcl, 25 mcg 10,147 6,111 $424K
J9202 Goserelin acetate implant, per 3.6 mg 1,014 944 $407K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 10,492 10,034 $399K
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg 723 511 $359K
Q5108 Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg 244 199 $312K
J9305 Injection, pemetrexed, not otherwise specified, 10 mg 75 50 $302K
J1453 Injection, fosaprepitant, 1 mg 3,525 2,300 $284K
96375 Therapeutic injection; each additional sequential IV push 17,810 9,331 $282K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 50,721 32,310 $275K
96417 7,953 4,847 $255K
80053 Comprehensive metabolic panel 33,774 24,224 $250K
Q5112 Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg 116 77 $250K
96416 4,356 2,578 $248K
J9395 Injection, fulvestrant, 25 mg 239 214 $190K
99205 Prolong outpt/office vis 1,628 1,621 $168K
J1437 Injection, ferric derisomaltose, 10 mg 120 119 $168K
J0640 Injection, leucovorin calcium, per 50 mg 3,695 2,152 $147K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 1,688 1,685 $140K
99232 Subsequent hospital care, per day, moderate complexity 3,703 1,883 $137K
Q5119 Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg 44 31 $135K
J9358 Injection, fam-trastuzumab deruxtecan-nxki, 1 mg 19 12 $124K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 4,365 3,212 $118K
96401 3,407 1,763 $109K
J0185 Injection, aprepitant, 1 mg 507 339 $107K
36415 Collection of venous blood by venipuncture 33,520 21,661 $104K
99239 Hospital discharge day management, more than 30 minutes 1,905 1,689 $103K
96415 6,383 4,043 $103K
96411 3,221 2,168 $95K
96367 5,851 3,584 $94K
J9070 Cyclophosphamide, 100 mg 331 222 $87K
J9190 Injection, fluorouracil, 500 mg 4,755 2,808 $65K
J1750 Injection, iron dextran, 50 mg 266 260 $63K
J9263 Injection, oxaliplatin, 0.5 mg 2,242 1,115 $56K
J9206 Injection, irinotecan, 20 mg 1,835 1,067 $51K
J0897 Injection, denosumab, 1 mg 27 25 $51K
82728 5,021 4,818 $51K
J3489 Injection, zoledronic acid, 1 mg 1,944 1,819 $51K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 3,449 1,881 $49K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3,112 2,084 $48K
84443 Thyroid stimulating hormone (TSH) 4,105 3,526 $48K
99245 402 394 $47K
J9045 Injection, carboplatin, 50 mg 2,625 1,589 $46K
J9267 Injection, paclitaxel, 1 mg 2,913 1,136 $39K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 7,214 5,057 $39K
96402 2,484 2,303 $39K
99244 Office or other outpatient consultation, moderate to high complexity 394 388 $39K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 2,707 1,540 $36K
J9171 Injection, docetaxel, 1 mg 322 243 $33K
84466 3,447 3,347 $32K
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg 1,064 513 $29K
83735 5,808 3,741 $26K
96368 2,677 1,614 $25K
J9217 Leuprolide acetate (for depot suspension), 7.5 mg 119 117 $24K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 415 414 $24K
96361 Intravenous infusion, hydration; each additional hour 3,483 2,030 $23K
82024 1,030 882 $23K
J9071 Injection, cyclophosphamide (auromedics), 5 mg 47 25 $23K
83615 5,510 4,887 $23K
36430 1,301 686 $19K
99195 398 326 $19K
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units 109 50 $18K
96409 491 222 $18K
83540 3,811 3,703 $18K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 16,898 8,987 $18K
82607 1,731 1,719 $17K
J2997 Injection, alteplase recombinant, 1 mg 116 107 $15K
82746 1,389 1,380 $15K
82378 1,005 937 $14K
86300 796 743 $13K
85055 670 350 $11K
82784 674 652 $11K
J9000 Injection, doxorubicin hydrochloride, 10 mg 529 338 $10K
J7030 Infusion, normal saline solution , 1000 cc 5,396 2,759 $10K
82533 993 849 $9K
83521 474 460 $9K
J1756 Injection, iron sucrose, 1 mg 287 90 $8K
J9060 Injection, cisplatin, powder or solution, 10 mg 721 354 $8K
96523 652 604 $8K
85610 2,568 2,147 $8K
J9075 Injection, cyclophosphamide, not otherwise specified, 5 mg 46 27 $8K
99222 Initial hospital care, per day, moderate complexity 108 107 $7K
96377 792 608 $6K
84165 922 900 $6K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 313 311 $6K
86704 662 655 $6K
87340 696 689 $5K
90791 Psychiatric diagnostic evaluation 68 63 $5K
J1200 Injection, diphenhydramine hcl, up to 50 mg 7,396 3,480 $4K
J0461 Injection, atropine sulfate, 0.01 mg 1,447 843 $4K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 153 147 $4K
J3490 Unclassified drugs 3,387 1,517 $3K
86706 453 450 $3K
85046 782 746 $3K
G9001 Coordinated care fee, initial rate 69 69 $3K
38222 38 38 $3K
J1626 Injection, granisetron hydrochloride, 100 mcg 1,094 552 $3K
85730 629 576 $3K
90834 Psychotherapy, 45 minutes with patient 64 54 $3K
84100 859 593 $2K
J9181 Injection, etoposide, 10 mg 244 72 $2K
84439 347 309 $2K
J3475 Injection, magnesium sulfate, per 500 mg 1,646 791 $2K
81000 667 545 $2K
J3480 Injection, potassium chloride, per 2 meq 1,493 760 $2K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 154 150 $2K
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 1,432 1,252 $2K
84550 495 368 $2K
99231 Subsequent hospital care, per day, straightforward or low complexity 74 48 $1K
G9002 Coordinated care fee, maintenance rate 60 58 $1K
36593 85 80 $1K
84703 200 149 $1K
80048 Basic metabolic panel (calcium, ionized) 157 121 $1K
85651 223 221 $721.86
84156 359 298 $636.49
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion 138 48 $582.38
99442 45 44 $530.94
G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion 60 60 $423.62
82565 107 105 $352.58
99441 40 40 $266.89
J2919 Injection, methylprednisolone sodium succinate, 5 mg 125 67 $251.02
J2060 Injection, lorazepam, 2 mg 462 274 $248.98
83883 415 210 $233.68
86140 41 38 $173.51
86301 14 13 $159.95
83010 13 13 $116.10
82550 24 24 $109.24
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 46 26 $48.34
J2270 Injection, morphine sulfate, up to 10 mg 17 12 $47.70
S0028 Injection, famotidine, 20 mg 41 13 $0.84